Adoptive cellular therapies: the current landscape.

Rohaan MW, Wilgenhof S, Haanen JBAG. · 2019

Read Adoptive cellular therapies: the current landscape. by Rohaan MW, Wilgenhof S, Haanen JBAG. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6447513.txt.

Description

Rohaan and co-authors review adoptive cellular therapies, treatments that give cancer patients living immune cells trained or engineered to attack their tumors. Three families are covered: tumor-infiltrating lymphocytes harvested from the tumor, T cells fitted with new receptors, and CAR T cells carrying synthetic chimeric receptors.

The standout success is CD19-directed CAR T therapy in blood cancers, already commercially approved by the FDA when the review appeared. Toxicity receives frank treatment, since these potent cells can harm healthy tissue and trigger severe reactions. Sections on target choice and cell engineering close with where trials worldwide are pushing the approach, especially into solid tumors.

Catalog record

CREATORRohaan MW, Wilgenhof S, Haanen JBAG.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6447513

Browse the full library · About the Tower of Babel